ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,798.74
-0.15%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) 뉴스

VRDN Viridian Therapeutics Inc

16.30
1.72 (11.80%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Viridian Therapeutics Inc VRDN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
1.72 11.80% 16.30 09:00:00
개장가 저가 고가 종가 전일 종가
15.08 15.01 15.50 15.40 14.58
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202421:00BWViridian Therapeutics Announces Inducement Grants Under..
29/04/202421:00BWViridian Therapeutics to Webcast First Quarter 2024..
05/04/202405:01BWViridian Therapeutics Announces Inducement Grants Under..
07/03/202406:01BWViridian Therapeutics Announces Inducement Grants Under..
05/03/202422:00BWViridian Therapeutics to Participate in the Leerink Partners..
29/02/202406:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/02/202406:07EDGAR2Form 8-K - Current report
28/02/202406:01BWViridian Therapeutics Highlights Recent Progress and Reports..
16/02/202422:00BWViridian Therapeutics Appoints Jennifer Tousignant as Chief..
15/02/202410:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202406:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:01BWViridian Therapeutics Announces Inducement Grant Under..
25/01/202408:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202407:12EDGAR2Form SC 13D/A - General statement of acquisition of..
20/01/202407:22EDGAR2Form 8-K - Current report
20/01/202406:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/01/202412:00BWViridian Therapeutics Announces Pricing of Public Offering..
18/01/202406:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/01/202406:01BWViridian Therapeutics Announces Proposed Underwritten Public..
13/01/202406:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/01/202422:08EDGAR2Form 8-K - Current report
08/01/202422:00BWViridian Therapeutics to Present Key 2024 Corporate..
04/01/202422:00BWViridian Therapeutics to Webcast Presentation at the 42nd..
19/12/202301:45EDGAR2Form 144 - Report of proposed sale of securities
18/12/202322:15EDGAR2Form 8-K - Current report
18/12/202321:00BWViridian Therapeutics Announces Positive Clinical Data in..
13/12/202306:19EDGAR2Form 144 - Report of proposed sale of securities
09/12/202306:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/12/202306:22EDGAR2Form 144 - Report of proposed sale of securities
02/12/202306:04EDGAR2Form 144 - Report of proposed sale of securities
01/12/202306:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
21/11/202322:00BWViridian Therapeutics to Participate in 6th Annual Evercore..
14/11/202307:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:01BWViridian Therapeutics Reports Third Quarter 2023 Financial..
08/11/202322:00BWViridian Therapeutics to Participate in the Jefferies London..
04/11/202305:30EDGAR2Form SC 13D/A - General statement of acquisition of..
03/11/202321:00BWViridian Therapeutics Announces Encore Presentations at the..
02/11/202310:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/11/202305:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202321:35EDGAR2Form 8-K - Current report
30/10/202321:30BWViridian Therapeutics Appoints New Chief Executive Officer,..

최근 히스토리

NASDAQ
VRDN
Viridian Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유